<!-- NLMSF Staging vs Grading Main Content -->
<div class="nlmsf-content-intro">
  <p>
    Understanding the difference between staging and grading is crucial for patients with cancer, 
    including those with Leiomyosarcoma (LMS). This page explains these concepts, their importance 
    in treatment planning, and specific information relevant to sarcoma patients.
  </p>
</div>

<!-- Overview Section -->
<div id="overview" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title blue">Overview: Staging vs Grading</h2>
  
  <div id="basic-concepts" class="nlmsf-subsection blue">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle blue">
        <i class="fas fa-info"></i>
      </div>
      <div>
        <h3>Basic Concepts</h3>
        <p>Understanding staging and grading fundamentals</p>
      </div>
    </div>
    
    <p>
      When a patient is diagnosed with cancer, healthcare professionals use two distinct but complementary 
      classification systems to assess the cancer: <span class="font-bold">staging</span> and <span class="font-bold">grading</span>.
    </p>
    
    <div class="nlmsf-concept-grid">
      <div class="nlmsf-concept-card">
        <div class="nlmsf-concept-icon blue">
          <i class="fas fa-balance-scale"></i>
        </div>
        <h4>Grading</h4>
        <p>
          <span class="font-bold">Assesses the appearance of cancer cells</span> under a microscope, 
          indicating how aggressive the cancer cells look compared to normal cells and how quickly they might grow and spread.
        </p>
      </div>
      
      <div class="nlmsf-concept-card">
        <div class="nlmsf-concept-icon blue">
          <i class="fas fa-bullseye"></i>
        </div>
        <h4>Staging</h4>
        <p>
          <span class="font-bold">Evaluates the extent of cancer</span> in the body, including the size of the tumor, 
          its location, and whether it has spread to nearby lymph nodes or other parts of the body.
        </p>
      </div>
    </div>
  </div>
  
  <div id="purpose" class="nlmsf-subsection blue">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle blue">
        <i class="fas fa-clipboard-check"></i>
      </div>
      <div>
        <h3>Purpose & Use</h3>
        <p>How these classifications guide treatment decisions</p>
      </div>
    </div>
    
    <p>
      Both staging and grading serve important but different purposes in cancer care:
    </p>
    
    <ul class="nlmsf-bullet-list">
      <li>
        <span class="font-bold">Diagnosis:</span> They help confirm and characterize the type of cancer.
      </li>
      <li>
        <span class="font-bold">Prognosis:</span> They provide insight into the likely course of the disease.
      </li>
      <li>
        <span class="font-bold">Treatment Planning:</span> They guide decisions about appropriate treatment options.
      </li>
      <li>
        <span class="font-bold">Research:</span> They enable comparison of similar cases in clinical studies.
      </li>
      <li>
        <span class="font-bold">Communication:</span> They provide standardized terms for healthcare providers to discuss cases.
      </li>
    </ul>
  </div>
</div>

<!-- Grading Section -->
<div id="grading" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title teal">Cancer Grading</h2>
  
  <div id="grading-definition" class="nlmsf-subsection teal">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle teal">
        <i class="fas fa-microscope"></i>
      </div>
      <div>
        <h3>Definition & Purpose</h3>
        <p>What cancer grading tells us about the disease</p>
      </div>
    </div>
    
    <p>
      Grading is a measure of <span class="font-bold">how abnormal the cancer cells look under a microscope</span> compared to healthy cells. 
      The more abnormal the cells appear, the higher the grade and the more aggressive the cancer is likely to be.
    </p>
    
    <div class="nlmsf-info-box teal">
      <div class="nlmsf-info-box-icon">
        <i class="fas fa-lightbulb"></i>
      </div>
      <div class="nlmsf-info-box-content">
        <h4>Key Fact</h4>
        <p>
          Grading focuses on the cellular characteristics and is primarily determined by a pathologist examining tissue samples 
          under a microscope after a biopsy or surgery.
        </p>
      </div>
    </div>
  </div>
  
  <div id="grading-systems" class="nlmsf-subsection teal">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle teal">
        <i class="fas fa-list-ol"></i>
      </div>
      <div>
        <h3>Grading Systems</h3>
        <p>Different ways cancer cells are classified by appearance</p>
      </div>
    </div>
    
    <p>
      Different cancers use specific grading systems, but most follow similar principles:
    </p>
    
    <div class="nlmsf-grading-table">
      <div class="nlmsf-grading-row header">
        <div class="nlmsf-grading-cell">Grade</div>
        <div class="nlmsf-grading-cell">Description</div>
        <div class="nlmsf-grading-cell">Characteristics</div>
      </div>
      
      <div class="nlmsf-grading-row">
        <div class="nlmsf-grading-cell grade">Grade 1<br><span>(Low Grade)</span></div>
        <div class="nlmsf-grading-cell">Well-differentiated</div>
        <div class="nlmsf-grading-cell">
          Cells look similar to normal cells and are well-organized.
          <br>Generally slow-growing with less tendency to spread.
        </div>
      </div>
      
      <div class="nlmsf-grading-row">
        <div class="nlmsf-grading-cell grade">Grade 2</div>
        <div class="nlmsf-grading-cell">Moderately differentiated</div>
        <div class="nlmsf-grading-cell">
          Cells have features between low and high grade.
          <br>Moderately abnormal appearance and growth rate.
        </div>
      </div>
      
      <div class="nlmsf-grading-row">
        <div class="nlmsf-grading-cell grade">Grade 3<br><span>(High Grade)</span></div>
        <div class="nlmsf-grading-cell">Poorly differentiated</div>
        <div class="nlmsf-grading-cell">
          Cells look very abnormal and disorganized.
          <br>Tend to grow rapidly and spread more aggressively.
        </div>
      </div>
      
      <div class="nlmsf-grading-row">
        <div class="nlmsf-grading-cell grade">Grade 4<br><span>(High Grade)</span></div>
        <div class="nlmsf-grading-cell">Undifferentiated</div>
        <div class="nlmsf-grading-cell">
          Cells look primitive and immature.
          <br>Very aggressive with high risk of spreading.
        </div>
      </div>
    </div>
    
    <p class="nlmsf-note">
      <span class="font-bold">Note:</span> For soft tissue sarcomas like LMS, the French Federation of Cancer Centers Sarcoma 
      Group (FNCLCC) system is commonly used, which evaluates differentiation, mitotic count, and necrosis.
    </p>
  </div>
</div>

<!-- Staging Section -->
<div id="staging" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title indigo">Cancer Staging</h2>
  
  <div id="staging-definition" class="nlmsf-subsection indigo">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle indigo">
        <i class="fas fa-map-marker-alt"></i>
      </div>
      <div>
        <h3>Definition & Purpose</h3>
        <p>What cancer staging tells us about the disease</p>
      </div>
    </div>
    
    <p>
      Staging describes the <span class="font-bold">extent or spread of cancer at the time of diagnosis</span>. 
      It helps determine how serious the cancer is and the best treatment options.
    </p>
    
    <div class="nlmsf-info-box indigo">
      <div class="nlmsf-info-box-icon">
        <i class="fas fa-lightbulb"></i>
      </div>
      <div class="nlmsf-info-box-content">
        <h4>Key Fact</h4>
        <p>
          Staging is determined through physical exams, imaging tests (CT scans, MRIs, PET scans), lab tests, pathology 
          reports from biopsies, and sometimes surgical findings.
        </p>
      </div>
    </div>
  </div>
  
  <div id="staging-systems" class="nlmsf-subsection indigo">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle indigo">
        <i class="fas fa-bullseye"></i>
      </div>
      <div>
        <h3>TNM System & Grading</h3>
        <p>Understanding how cancer is classified and staged</p>
      </div>
    </div>
    
    <div class="nlmsf-tnm-factors-grid">
      <div class="nlmsf-tnm-factor-card indigo">
        <div class="nlmsf-tnm-letter"><span>T</span></div>
        <p>Size of the tumor</p>
      </div>
        
      <div class="nlmsf-tnm-factor-card amber">
        <div class="nlmsf-tnm-letter"><span>N</span></div>
        <p>Spread to lymph nodes (small bean-shaped collections of immune system cells found throughout the body that help fight infections and cancers)</p>
      </div>
        
      <div class="nlmsf-tnm-factor-card rose">
        <div class="nlmsf-tnm-letter"><span>M</span></div>
        <p>Metastasis (spread to distant organs)</p>
      </div>
    </div>
    
    <div class="nlmsf-stage-table">
      <div class="nlmsf-stage-row header">
        <div class="nlmsf-stage-cell">Stage</div>
        <div class="nlmsf-stage-cell">Description</div>
      </div>
      
      <div class="nlmsf-stage-row">
        <div class="nlmsf-stage-cell stage">Stage I</div>
        <div class="nlmsf-stage-cell">
          Early-stage cancer that is still localized to the original site.
          <br>Typically small tumors without spread to lymph nodes or other parts of the body.
        </div>
      </div>
      
      <div class="nlmsf-stage-row">
        <div class="nlmsf-stage-cell stage">Stage II</div>
        <div class="nlmsf-stage-cell">
          Locally advanced cancer that may be larger in size.
          <br>May involve nearby tissues but has not spread to lymph nodes or distant sites.
        </div>
      </div>
      
      <div class="nlmsf-stage-row">
        <div class="nlmsf-stage-cell stage">Stage III</div>
        <div class="nlmsf-stage-cell">
          More advanced cancer that may have spread to nearby lymph nodes.
          <br>May be larger and/or invade nearby structures.
        </div>
      </div>
      
      <div class="nlmsf-stage-row">
        <div class="nlmsf-stage-cell stage">Stage IV</div>
        <div class="nlmsf-stage-cell">
          Advanced cancer that has spread (metastasized) to distant parts of the body.
          <br>The most serious stage with metastasis to other organs or tissues.
        </div>
      </div>
    </div>
  </div>
  
  <div id="staging-methods" class="nlmsf-subsection indigo">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle indigo">
        <i class="fas fa-search"></i>
      </div>
      <div>
        <h3>Staging Methods</h3>
        <p>How doctors determine the stage of cancer</p>
      </div>
    </div>
    
    <p>
      Staging is a complex process that integrates information from multiple sources:
    </p>
    
    <div class="nlmsf-methods-grid">
      <div class="nlmsf-method-card">
        <div class="nlmsf-method-icon indigo">
          <i class="fas fa-handshake"></i>
        </div>
        <h4>Clinical Staging</h4>
        <p>
          Based on physical exams, imaging studies, and initial biopsies before treatment begins.
        </p>
      </div>
      
      <div class="nlmsf-method-card">
        <div class="nlmsf-method-icon indigo">
          <i class="fas fa-procedures"></i>
        </div>
        <h4>Pathological Staging</h4>
        <p>
          Based on surgery and examination of removed tissue, providing more accurate information.
        </p>
      </div>
      
      <div class="nlmsf-method-card">
        <div class="nlmsf-method-icon indigo">
          <i class="fas fa-sync-alt"></i>
        </div>
        <h4>Restaging</h4>
        <p>
          Determines if cancer has progressed, regressed, or remained stable after treatment.
        </p>
      </div>
    </div>
  </div>
</div>

<!-- Differences Section -->
<div id="differences" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title purple">Key Differences</h2>
  
  <div class="nlmsf-subsection purple">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle purple">
        <i class="fas fa-not-equal"></i>
      </div>
      <div>
        <h3>Staging vs Grading: Understanding the Distinctions</h3>
        <p>How these two systems differ but work together</p>
      </div>
    </div>
    
    <div class="nlmsf-comparison-table">
      <div class="nlmsf-comparison-row header">
        <div class="nlmsf-comparison-cell">Aspect</div>
        <div class="nlmsf-comparison-cell">Staging</div>
        <div class="nlmsf-comparison-cell">Grading</div>
      </div>
      
      <div class="nlmsf-comparison-row">
        <div class="nlmsf-comparison-cell aspect">Focus</div>
        <div class="nlmsf-comparison-cell">
          <i class="fas fa-globe-americas"></i><br>
          Extent and spread of cancer in the body
        </div>
        <div class="nlmsf-comparison-cell">
          <i class="fas fa-microscope"></i><br>
          Appearance and behavior of cancer cells
        </div>
      </div>
      
      <div class="nlmsf-comparison-row">
        <div class="nlmsf-comparison-cell aspect">Assessment</div>
        <div class="nlmsf-comparison-cell">
          Based on tumor size, lymph node involvement, and metastasis (TNM system)
        </div>
        <div class="nlmsf-comparison-cell">
          Based on cellular appearance, differentiation, and other microscopic features
        </div>
      </div>
      
      <div class="nlmsf-comparison-row">
        <div class="nlmsf-comparison-cell aspect">Methods</div>
        <div class="nlmsf-comparison-cell">
          Physical exams, imaging (CT, MRI, PET), surgery, biopsies
        </div>
        <div class="nlmsf-comparison-cell">
          Microscopic examination of tissue samples by a pathologist
        </div>
      </div>
      
      <div class="nlmsf-comparison-row">
        <div class="nlmsf-comparison-cell aspect">Purpose</div>
        <div class="nlmsf-comparison-cell">
          Guides treatment decisions and predicts prognosis based on cancer's physical spread
        </div>
        <div class="nlmsf-comparison-cell">
          Indicates aggressiveness and potential behavior of the cancer
        </div>
      </div>
      
      <div class="nlmsf-comparison-row">
        <div class="nlmsf-comparison-cell aspect">Timing</div>
        <div class="nlmsf-comparison-cell">
          Can change over time as cancer progresses or responds to treatment
        </div>
        <div class="nlmsf-comparison-cell">
          Generally remains consistent throughout the course of the disease
        </div>
      </div>
    </div>
    
    <div class="nlmsf-info-box purple">
      <div class="nlmsf-info-box-icon">
        <i class="fas fa-lightbulb"></i>
      </div>
      <div class="nlmsf-info-box-content">
        <h4>Important Note</h4>
        <p>
          A high-grade tumor (more aggressive cells) can be found at any stage. Similarly, a low-grade tumor 
          (less aggressive cells) could potentially be at an advanced stage if it has spread widely.
        </p>
      </div>
    </div>
  </div>
</div>

<!-- Importance Section -->
<div id="importance" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title rose">Importance in Treatment Planning</h2>
  
  <div class="nlmsf-subsection rose">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle rose">
        <i class="fas fa-stethoscope"></i>
      </div>
      <div>
        <h3>Medical Decision Making</h3>
        <p>How staging and grading influence your care</p>
      </div>
    </div>
    
    <p>
      Both staging and grading play crucial roles in determining the most appropriate treatment approach:
    </p>
    
    <div class="nlmsf-treatment-grid">
      <div class="nlmsf-treatment-card">
        <div class="nlmsf-treatment-icon rose">
          <i class="fas fa-pills"></i>
        </div>
        <h4>Treatment Selection</h4>
        <p>
          Staging and grading help determine whether surgery, radiation therapy, chemotherapy, 
          targeted therapy, immunotherapy, or a combination is most appropriate.
        </p>
      </div>
      
      <div class="nlmsf-treatment-card">
        <div class="nlmsf-treatment-icon rose">
          <i class="fas fa-chart-line"></i>
        </div>
        <h4>Prognosis</h4>
        <p>
          They provide information about the expected course of the disease and likelihood of 
          recovery, helping patients understand their outlook.
        </p>
      </div>
      
      <div class="nlmsf-treatment-card">
        <div class="nlmsf-treatment-icon rose">
          <i class="fas fa-users"></i>
        </div>
        <h4>Clinical Trials</h4>
        <p>
          Staging and grading can determine eligibility for clinical trials, potentially 
          providing access to cutting-edge treatments.
        </p>
      </div>
      
      <div class="nlmsf-treatment-card">
        <div class="nlmsf-treatment-icon rose">
          <i class="fas fa-comments"></i>
        </div>
        <h4>Communication</h4>
        <p>
          They provide a common language for healthcare providers to discuss cases and 
          for patients to better understand their condition.
        </p>
      </div>
    </div>
    
    <div class="nlmsf-quote-box">
      <i class="fas fa-quote-left"></i>
      <blockquote>
        "Understanding your cancer's stage and grade empowers you to participate more actively in treatment decisions and to have 
        more informed discussions with your healthcare team."
      </blockquote>
    </div>
  </div>
</div>

<!-- Sarcoma-Specific Section -->
<div id="sarcoma-specific" class="nlmsf-content-section">
  <h2 class="nlmsf-section-title amber">Sarcoma-Specific Information</h2>
  
  <div class="nlmsf-subsection amber">
    <div class="nlmsf-subsection-header">
      <div class="icon-circle amber">
        <i class="fas fa-dna"></i>
      </div>
      <div>
        <h3>LMS and Other Sarcomas</h3>
        <p>Special considerations for soft tissue sarcomas</p>
      </div>
    </div>
    
    <p>
      Soft tissue sarcomas, including Leiomyosarcoma (LMS), have some unique characteristics in their staging and grading:
    </p>
    
    <div class="nlmsf-info-box amber">
      <div class="nlmsf-info-box-icon">
        <i class="fas fa-exclamation-circle"></i>
      </div>
      <div class="nlmsf-info-box-content">
        <h4>Important for Sarcoma Patients</h4>
        <p>
          For sarcomas, grade is often incorporated into the staging system, highlighting how critical the cellular 
          characteristics are in determining the behavior of these rare cancers.
        </p>
      </div>
    </div>
    
    <h4 class="nlmsf-subsection-subtitle">Sarcoma Grading Systems</h4>
    
    <p>
      The most widely used grading system for soft tissue sarcomas is the French Federation of Cancer Centers Sarcoma 
      Group (FNCLCC) system, which scores three factors:
    </p>
    
    <ul class="nlmsf-bullet-list">
      <li>
        <span class="font-bold">Differentiation Score:</span> How closely the cancer cells resemble normal cells
      </li>
      <li>
        <span class="font-bold">Mitotic Count:</span> How many cancer cells are actively dividing
      </li>
      <li>
        <span class="font-bold">Tumor Necrosis:</span> How much of the tumor is made up of dying tissue
      </li>
    </ul>
    
    <p>
      These scores are added to determine the grade:
    </p>
    
    <ul class="nlmsf-bullet-list highlight">
      <li>Grade 1: Total score of 2-3</li>
      <li>Grade 2: Total score of 4-5</li>
      <li>Grade 3: Total score of 6-8</li>
    </ul>
    
    <h4 class="nlmsf-subsection-subtitle">Sarcoma Staging</h4>
    
    <p>
      The American Joint Committee on Cancer (AJCC) system for soft tissue sarcomas considers:
    </p>
    
    <ul class="nlmsf-bullet-list">
      <li>
        <span class="font-bold">Tumor size and depth:</span> Larger and deeper tumors generally have a worse prognosis
      </li>
      <li>
        <span class="font-bold">Lymph node involvement:</span> Though less common in sarcomas than in other cancers
      </li>
      <li>
        <span class="font-bold">Distant metastasis:</span> Often to the lungs in sarcomas
      </li>
      <li>
        <span class="font-bold">Grade:</span> A critical factor that significantly influences staging in sarcomas
      </li>
    </ul>
    
    <div class="nlmsf-tips-box">
      <h4>Tips for Patients</h4>
      <ul class="nlmsf-tips-list">
        <li>Always ask for clarification about both the stage and grade of your sarcoma</li>
        <li>Request copies of your pathology and imaging reports</li>
        <li>Consider seeking a second opinion from a sarcoma specialist, as these are rare cancers</li>
        <li>Join patient support groups to connect with others who understand your experience</li>
        <li>Keep a record of your test results and treatment history</li>
      </ul>
    </div>
  </div>
</div>
